Etanercept (Enbrel) ELISA Kit

Etanercept is a biologic medication used to treat several autoimmune conditions, including rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis. It works by inhibiting the action of tumor necrosis factor-alpha (TNF-α), a cytokine that plays a pivotal role in promoting inflammation and immune system dysregulation. By blocking TNF-α, Etanercept helps to reduce inflammation, alleviate symptoms, and improve the quality of life for patients suffering from these chronic inflammatory diseases.

The Etanercept (Enbrel) ELISA Kit is a highly accurate immunological test designed for the precise measurement of Etanercept levels in serum or plasma samples. This test allows researchers, clinicians, and pharmaceutical professionals to closely monitor the concentration of Etanercept in a patient’s system, providing invaluable insights into the drug’s pharmacokinetics and effectiveness. It plays a key role in ensuring that patients are receiving the correct dosage and that the drug remains within the therapeutic range throughout their treatment.

This ELISA kit is particularly important in clinical settings where personalized medicine is critical. Monitoring Etanercept levels can help optimize treatment protocols, reducing the risk of adverse effects or therapeutic failures. By measuring drug concentrations, clinicians can also make informed decisions regarding dosage adjustments or potential switch to alternative therapies. Additionally, the kit is beneficial for conducting pharmacokinetic studies, which are essential for understanding how Etanercept is absorbed, distributed, metabolized, and eliminated by the body.

For researchers, the Etanercept (Enbrel) ELISA Kit offers a reliable method to explore the drug’s efficacy and safety, making it indispensable for clinical trials and studies. It is designed for use in both routine clinical practice and specialized research laboratories, where its precision and reproducibility make it a trusted tool in therapeutic monitoring. With its ability to measure Etanercept levels over a broad dynamic range, the kit ensures that the monitoring process is both accurate and efficient, helping to optimize patient care and contribute to the advancement of treatment strategies for autoimmune diseases.

• Therapeutic Monitoring: The Etanercept (Enbrel) ELISA Kit allows healthcare providers to monitor the drug levels in patients receiving Etanercept therapy. By ensuring that the drug concentration is within the therapeutic range, healthcare professionals can optimize treatment effectiveness, reducing the risk of adverse effects and ensuring the drug’s optimal efficacy.

• Pharmacokinetic Studies: The kit enables the study of Etanercept’s pharmacokinetics, including its distribution, metabolism, and elimination in the body. This is essential for understanding how the drug behaves in different individuals and helps tailor personalized treatment plans. It provides valuable data to enhance clinical decision-making and refine dosing regimens.

• Adverse Effect Monitoring: Monitoring Etanercept levels is crucial for identifying potential adverse effects that may arise from suboptimal or excessive drug concentrations. By assessing drug levels, clinicians can adjust the dosage to minimize risks such as infections or side effects related to overexposure, ensuring patient safety during treatment.

• Bioavailability and Bioequivalence Studies: The Etanercept (Enbrel) ELISA Kit can also be used to evaluate the bioavailability and bioequivalence of different formulations or biosimilars of Etanercept. This information helps to assess the safety and effectiveness of alternative treatments, contributing to the development of comparable drugs for patients.

• High Sensitivity: The Etanercept (Enbrel) ELISA Kit is designed to detect even low levels of Etanercept in serum or plasma samples. This high sensitivity ensures accurate measurement of the drug at all stages of treatment, making it a reliable tool for clinical monitoring, even when drug levels are minimal.

• Quick and Easy Application: The ELISA Kit offers a streamlined and simple protocol for rapid results. The user-friendly process ensures that clinicians and researchers can efficiently measure Etanercept levels, saving valuable time while still providing precise data necessary for patient care and treatment adjustments.

• Specificity: The kit utilizes highly specific antibodies that target Etanercept with precision, reducing the risk of false positives. This specificity ensures that results are accurate and reliable, giving healthcare providers confidence in the data used to make critical treatment decisions for patients.

• Wide Dynamic Range: The Etanercept (Enbrel) ELISA Kit provides an extensive dynamic range, allowing for accurate measurement of Etanercept across a broad concentration spectrum. This versatility ensures that both low and high drug concentrations can be measured accurately, offering comprehensive monitoring throughout the treatment process.

96 well plates are coated with TNF-α to capture Etanercept from the sample, ensuring specific binding and accurate detection.

Sensitivity: 98.5%

Specificity: 99%

SC-ETA-001